Effects of the substituted (S)-3-phenylpiperidine (?)-OSU6162 on PET measurements in subhuman primates: Evidence for tone-dependent normalization of striatal dopaminergic activity
Autor: | Bengt Långström, Clas Sonesson, Per Hartvig, Joakim Tedroff, Richard Torstenson, Karl-Johan Fasth, Henrik Neu, Arvid Carlsson, Nicholas Waters |
---|---|
Rok vydání: | 1998 |
Předmět: |
medicine.medical_specialty
Phenylpiperidine Dopamine Dopamine Agents Inhibitory postsynaptic potential Levodopa Cellular and Molecular Neuroscience chemistry.chemical_compound Piperidines Downregulation and upregulation Reference Values In vivo Internal medicine Dopamine receptor D2 medicine Animals Chemistry Functional correlation Dopaminergic Biopterin Macaca mulatta Corpus Striatum Endocrinology Dopamine Antagonists Tyrosine Female Tomography Emission-Computed medicine.drug |
Zdroj: | Synapse. 28:280-287 |
ISSN: | 1098-2396 0887-4476 |
DOI: | 10.1002/(sici)1098-2396(199804)28:4<280::aid-syn3>3.0.co;2-5 |
Popis: | (−)-OSU6162 is a substituted (S)-3-phenylpiperidine derivative which exhibits some affinity to the dopamine D2 receptor family. In vivo, the compound displays a unique normalizing profile on psychomotor activity by an intriguing mixture of stimulatory and inhibitory properties. In the present investigation, some of the effects of (−)-OSU6162 on central dopaminergic function were studied by positron emission tomography (PET) and L-[11C]DOPA in anaesthetized female rhesus monkeys. (−)-OSU6162 displayed a dopaminergic tone-dependent effect with a reduction in the striatal L-[11C]DOPA influx rate in monkeys with high baseline values and an increased striatal L-[11C]DOPA influx rate in animals with low baseline values. Infusion of (−)-OSU6162 for a whole day resulted in a stable effect with no evidence of tolerance. (−)-OSU6162 also stabilized dopaminergic function by attenuating the upregulation of the striatal L-[11C]DOPA influx rate which has previously been shown to occur following 6R-BH4 or 6R-BH4 + L-tyrosine infusions. This “Protean” effect of (−)-OSU6162 on the striatal dopaminergic function corresponds to previous behavioral observations in intact animals and demonstrates a true functional correlation to the measures obtained with L-[11C]DOPA and PET. The normalizing and stabilizing profile of (−)-OSU6162 should be of value in treating a variety of disorders where an underlying dysregulation or disruption of dopaminergic function can be assumed. Synapse 28:280–287, 1998. © 1998 Wiley-Liss, Inc. |
Databáze: | OpenAIRE |
Externí odkaz: |